Browse result page of B3Pdb

The total number entries retrieved from this search are 318, scroll left/right for detailed information.

B3pdbID	PEPTIDE NAME	PEPTIDE SEQUENCE (1-letter)	PEPTIDE SEQUENCE (3-letter)	N-TERMINAL MODIFICATION	C-TERMINAL MODIFICATION	CHEMICAL MODIFICATION	PEPTIDE LENGTH	PEPTIDE CONFORMATION	PEPTIDE NATURE	SOURCE/ORIGIN OF PEPTIDE	SMILES	CELL LINE	In vitro CONCENTRATION	In vitro METHOD	In vitro RESULT	ANIMAL MODEL	In vivo CONCENTRATION	In vivo MODE OF DELIVERY	In vivo METHOD	In vivo RESULT	ACTION	TRANSPORT TYPE	SUBCELLULAR LOCALISATION	COMBINATION	PHYSICAL CONDITION	RESPONSE	RESULT	LABEL	PMID
b3pdb_0983	pVEC	LLIILRRRIRKQAHAHSK-NH2	Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2	NA	NA	NA	18	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0.00602 mL/(g x min)	Direct iodination	26465925
b3pdb_0984	pVEC	LLIILRRRIRKQAHAHSK-NH2	Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2	NA	NA	NA	18	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Initial disrobution volume	0.02313 ml/g	Direct iodination	26465925
b3pdb_0988	Transportan 10	AGYLLGKINLKALAALAKKIL-NH2	Ala-Gly-Tyr-Leu-Leu-Gly-Lys-Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2	NA	NA	NA	21	Linear	NA	synthetic,viral	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0.00005 mL/(g x min)	Direct iodination	26465925
b3pdb_0989	Transportan 10	AGYLLGKINLKALAALAKKIL-NH2	Ala-Gly-Tyr-Leu-Leu-Gly-Lys-Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2	NA	NA	NA	21	Linear	NA	synthetic,viral	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Initial disrobution volume	0.00988 ml/g	Direct iodination	26465925
b3pdb_0993	TP10-2	AGYLLGKINLKPLAALAKKIL-NH2	Ala-Gly-Tyr-Leu-Leu-Gly-Lys-Ile-Asn-Leu-Lys-Pro-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2	NA	NA	NA	21	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0.000359 mL/(g x min)	Direct iodination	26465925
b3pdb_0994	TP10-2	AGYLLGKINLKPLAALAKKIL-NH2	Ala-Gly-Tyr-Leu-Leu-Gly-Lys-Ile-Asn-Leu-Lys-Pro-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2	NA	NA	NA	21	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Initial disrobution volume	0.01007 ml/g	Direct iodination	26465925
b3pdb_0998	D-[Ala1]-peptide T-a	aSTTTNYT-NH2	(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2	NA	NA	NA	8	Linear	NA	Chemically synthesized	C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0.00113 mL/(g x min)	Direct iodination	3440215
b3pdb_0999	D-[Ala1]-peptide T-a	aSTTTNYT-NH2	(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2	NA	NA	NA	8	Linear	NA	Chemically synthesized	C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Initial disrobution volume	0.0226 ml/g	Direct iodination	3440215
b3pdb_1000	D-[Ala1]-peptide T-a	aSTTTNYT-NH2	(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2	NA	NA	NA	8	Linear	NA	Chemically synthesized	C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0.0025 mL/(g x min)	Direct iodination	3440215
b3pdb_1001	D-[Ala1]-peptide T-a	aSTTTNYT-NH2	(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2	NA	NA	NA	8	Linear	NA	Chemically synthesized	C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Initial disrobution volume	0.0177 ml/g	Direct iodination	3440215
b3pdb_1002	D-[Ala1]-peptide T-a	aSTTTNYT-NH2	(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2	NA	NA	NA	8	Linear	NA	Chemically synthesized	C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0.00292 mL/(g x min)	Direct iodination	3440215
b3pdb_1003	D-[Ala1]-peptide T-a	aSTTTNYT-NH2	(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2	NA	NA	NA	8	Linear	NA	Chemically synthesized	C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Initial disrobution volume	0.0199 ml/g	Direct iodination	3440215
b3pdb_1004	D-[Ala1]-peptide T-a	aSTTTNYT-NH2	(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2	NA	NA	NA	8	Linear	NA	Chemically synthesized	C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0.0025 mL/(g x min)	Direct iodination	3440215
b3pdb_1005	D-[Ala1]-peptide T-a	aSTTTNYT-NH2	(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2	NA	NA	NA	8	Linear	NA	Chemically synthesized	C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Initial disrobution volume	0.0227 ml/g	Direct iodination	3440215
b3pdb_1009	NT1, Neurotensin8-13	(NαMe)RK-(3,4-dehydro)PWtLL	(NαMe)Arg-Lys-(3,4-dehydro)Pro-Trp-tLeu-Leu	NA	NA	NA	6	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	saturable	NA	NA	NA	Unidirectional influx rate constant	0.000512 mL/(g x min)	H3/C14	8574648
b3pdb_1010	NT1, Neurotensin8-13	(NαMe)RK-(3,4-dehydro)PWtLL	(NαMe)Arg-Lys-(3,4-dehydro)Pro-Trp-tLeu-Leu	NA	NA	NA	6	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	saturable	NA	NA	NA	Initial disrobution volume	0.0151 ml/g	H3/C14	8574648
b3pdb_1011	NT1, Neurotensin8-13	(NαMe)RK-(3,4-dehydro)PWtLL	(NαMe)Arg-Lys-(3,4-dehydro)Pro-Trp-tLeu-Leu	NA	NA	NA	6	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	saturable	NA	NA	NA	% injected dose	0.087 %/g	H3/C14	8574648
b3pdb_1037	MIF-1	PLG-NH2	Pro-Leu-Gly-NH2	NA	NA	NA	3	Linear	NA	NA	CC(C)CC(C(=O)NCC(=O)N)NC(=O)C1CCCN1	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	partially saturable	NA	NA	NA	Unidirectional influx rate constant	0.0237 mL/(g x min)	H3/C14	7912427
b3pdb_1038	MIF-1	PLG-NH2	Pro-Leu-Gly-NH2	NA	NA	NA	3	Linear	NA	NA	CC(C)CC(C(=O)NCC(=O)N)NC(=O)C1CCCN1	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Initial disrobution volume	-0.0173 ml/g	H3/C14	7912427
b3pdb_1043	β-Amyloid1-28	DAEFRHDSGYQVHHQKLVFFAEDVGSNK	Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys	NA	NA	NA	28	Linear	NA	NA	N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CO)C(=O)NCC(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(C(C)C)C(=O)NCC(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CCCCN)C(=O)O	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	non saturable	NA	NA	NA	Unidirectional influx rate constant	0.000386 mL/(g x min)	Direct iodination	1786560
b3pdb_1044	β-Amyloid1-28	DAEFRHDSGYQVHHQKLVFFAEDVGSNK	Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys	NA	NA	NA	28	Linear	NA	NA	N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CO)C(=O)NCC(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(C(C)C)C(=O)NCC(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CCCCN)C(=O)O	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	non saturable	NA	NA	NA	Initial disrobution volume	0.0159 ml/g	Direct iodination	1786560
b3pdb_1046	β-Amyloid1-40	DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV	Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val	NA	NA	NA	40	Linear	NA	human	CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CC4=CNC=N4)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC5=CC=C(C=C5)O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC6=CNC=N6)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)N	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	RadioactiInitial disrobution volumety ratio	7 (cpm brain/mg)/(cpm blood/µl)	direct iodination	26971931
b3pdb_1087	Insulin detemir, Lev	A-chain: Gly-Ile-Val-Glu-Gln-Cys-Cys-Thr-Ser-Ile-Cys-Ser-Leu-Tyr-Gln-Leu-Glu-Asn-Tyr-Cys-Asn B-chain:Phe-Val-Asn-Gln-His-Leu-Cys-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-myristic acid	A-chain:GIVEQCCTSICSLYQLENYCN B-chain: FVNQHLCGSHLVEALYLVCGERGFFYTPK-myristic acid	NA	NA	CysA6-CysA11; CysA7-CysB7; CysA20-CysB19	50	Linear	NA	Chemically synthesized	CCCCCCCCCCCCCC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]5CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N5)C(C)C)CC(C)C)CC7=CC=C(C=C7)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC8=CN=CN8)CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC9=CN=CN9)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CC=CC=C1)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N6)[C@@H](C)CC)CO)[C@@H](C)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)CN)CO)CC(C)C)CC1=CC=C(C=C1)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)N)C(=O)O	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0 mL/(g x min)	Direct iodination	20868713
b3pdb_1109	PhrANTH2	SKDYN	Ser-Lys-Asp-Tyr-Asn	NA	NA	NA	5	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0.00018 mL/(g x min)	Direct iodination	26536593
b3pdb_1110	PhrANTH2	SKDYN	Ser-Lys-Asp-Tyr-Asn	NA	NA	NA	5	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Initial disrobution volume	0.00659 ml/g	Direct iodination	26536593
b3pdb_1114	BIP-2	GLWEDLLYNINRYAHYIT	Gly-Leu-Trp-Glu-Asp-Leu-Leu-Tyr-Asn-Ile-Asn-Arg-Tyr-Ala-His-Tyr-Ile-Thr	NA	NA	NA	18	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0.00035 mL/(g x min)	Direct iodination	26536593
b3pdb_1115	BIP-2	GLWEDLLYNINRYAHYIT	Gly-Leu-Trp-Glu-Asp-Leu-Leu-Tyr-Asn-Ile-Asn-Arg-Tyr-Ala-His-Tyr-Ile-Thr	NA	NA	NA	18	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Initial disrobution volume	0.01267 ml/g	Direct iodination	26536593
b3pdb_1119	PhrCACET1	SYPGWSW	Ser-Tyr-Pro-Gly-Trp-Ser-Trp	NA	NA	NA	7	Linear	NA	bacterial	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0.00133 mL/(g x min)	Direct iodination	26536593
b3pdb_1120	PhrCACET1	SYPGWSW	Ser-Tyr-Pro-Gly-Trp-Ser-Trp	NA	NA	NA	7	Linear	NA	bacterial	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Initial disrobution volume	0.03553 ml/g	Direct iodination	26536593
b3pdb_1124	Neuromedin U	YKVNEYQGPVAPSGGFFLFRPRN	Tyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn	NA	NA	NA	25	Linear	NA	bacterial	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0.00131 mL/(g x min)	Direct iodination	27040796
b3pdb_1128	Neurotensin	ELYENLPRRPYIL	pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu	NA	NA	NA	13	Linear	NA	bacterial	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Initial disrobution volume	0.03383 ml/g	Direct iodination	27040796
b3pdb_1129	Neurotensin	ELYENLPRRPYIL	pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu	NA	NA	NA	13	Linear	NA	bacterial	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0.00075 mL/(g x min)	Direct iodination	27040796
b3pdb_1130	Neurotensin	ELYENLPRRPYIL	pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu	NA	NA	NA	13	Linear	NA	bacterial	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Initial disrobution volume	0.01125 ml/g	Direct iodination	27040796
b3pdb_1134	Neuromedin N	KIPYIL	Lys-Ile-Pro-Tyr-Ile-Leu	NA	NA	NA	6	Linear	NA	human	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant,initial	0.02299 ml/(g x min)	Direct iodination	27040796
b3pdb_1137	Neuromedin B	GNLWATGHFM	Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2	NA	NA	NA	10	Linear	NA	human	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0.00012 mL/(g x min)	Direct iodination	27040796
b3pdb_1138	Neuromedin B	GNLWATGHFM	Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2	NA	NA	NA	10	Linear	NA	human	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Initial disrobution volume	0.00799 ml/g	Direct iodination	27040796
b3pdb_1153	Beauvericin	NA	NA	NA	NA	NA	6	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0.01115 mL/(g x min)	Direct iodination	27349679
b3pdb_1154	Beauvericin	NA	NA	NA	NA	NA	6	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Initial disrobution volume	0.02191 ml/g	Direct iodination	27349679
b3pdb_1156	PepH1	VQQLTKRFSL	ValGlnGlnLeuThrLysArgPheSerLeu	NA	NA	NA	10	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	% injected dose	0.02 %/g	99mTc(CO)3+	28263555
b3pdb_1159	PepH3	AGILKRW	AlaGlyIleLeuLysArgTrp	NA	NA	NA	7	Linear	NA	viral	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	% injected dose	0.03 %/g	99mTc(CO)3+	28263555
b3pdb_1177	L57	TWPKHFDKHTFYSILKLGKH	Thr-Trp-Pro-Lys-His-Phe-Asp-Lys-His-Thr-Phe-Tyr-Ser-Ile-Leu-Lys-Leu-Gly-Lys-His	NA	NA	NA	20	Linear	NA	Hemoglobin	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	% injected dose	0.042 %/g	Direct iodination	29090274
b3pdb_1178	D3D3	RPRTRLHTHRNRRPRTRLHTHRNR	Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg	NA	NA	NA	24	Linear	NA	Hemoglobin	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Brain to plasma ratio	0.6	H3/C14	27086111
b3pdb_1179	RD2D3	PTLHTHNRRRRRRPRTRLHTHRNR	Pro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg	NA	NA	NA	24	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Brain to plasma ratio	0.6	H3/C14	27086111
b3pdb_1180	RD2D3	PTLHTHNRRRRRRPRTRLHTHRNR	Pro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg	NA	NA	NA	24	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Peak response	0.3 µL/(g x min)	H3/C14	27086111
b3pdb_1181	RD2D3	PTLHTHNRRRRRRPRTRLHTHRNR	Pro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg	NA	NA	NA	24	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0.0003 ml/(g x min)	H3/C14	27086111
b3pdb_1182	RD2D3	PTLHTHNRRRRRRPRTRLHTHRNR	Pro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg	NA	NA	NA	24	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Initial disrobution volume	0.0512 ml/g	H3/C14	27086111
b3pdb_1183	cRD2D3	PTLHTHNRRRRRRPRTRLHTHRNR	Pro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg	NA	NA	NA	24	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Peak response	2 µL/(g x min)	H3/C14	29225107
b3pdb_1184	cRD2D3	PTLHTHNRRRRRRPRTRLHTHRNR	Pro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg	NA	NA	NA	24	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0.002 ml/(g x min)	H3/C14	29225107
b3pdb_1185	cRD2D3	PTLHTHNRRRRRRPRTRLHTHRNR	Pro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg	NA	NA	NA	24	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Initial disrobution volume	0.1955 ml/g	H3/C14	29225107
b3pdb_1186	AH-D	SGSWLRDVWDWICTVLTDFKTWLQSKL	Ser-Gly-Ser-Trp-Leu-Arg-Asp-Val-Trp-Asp-Trp-Ile-Cys-Thr-Val-Leu-Thr-Asp-Phe-Lys-Thr-Trp-Leu-Gln-Ser-Lys-Leu	NA	NA	NA	27	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	NA	NA	Intravenous	NA	NA	NA	Permeability	NA	NA	NA	Unidirectional influx rate constant	0.0003853 mL/(g x min)	NA	30349030